Conversion to THA: A Treatment Path or a Treatment Failure?
Mark Owen Mcconkey, MD, FRCSC, CANADA Matthew J. Brick, MBChB, FRACS, NEW ZEALAND Parth Lodhia, MD, FRCSC, CANADA Thierry Pauyo, MD, FRCSC, CANADA
2021 Congress
Instructional Course Lecture
2021
group rating (28)
Participants will gain an understanding of the risk factors associated with Total Hip Arthroplasty (THA) conversion: Patient demographics, radiology, surgical technique and how to minimize early conversion in the first two years. The session will also provide a discussion of evidence that exists for treatment of FAI and non-arthritic hip disease in the prevention of future hip degenerative change.
This media is available to ISAKOS 2021: Global Registrants and On Demand purchases only.
Please log in or purchase to access.